辉瑞拟进一步减持约7.7%赫力昂股份

界面
15 Jan

辉瑞公司正在出售约7亿股赫力昂(Haleon)股份,相当于后者约7.7%的股份。辉瑞去年已出售过赫力昂股份,其中包括秋季的一笔价值24亿英镑的隔夜交易。赫力昂成立于2022年,由GSK和辉瑞的消费者健康业务合并而成。该公司生产多种产品,包括Panadol(必理通)止痛药片和Centrum(善存)维生素。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10